Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Common Equity (2022 - 2025)

Core Laboratories' Common Equity history spans 4 years, with the latest figure at $272.2 million for Q4 2025.

  • For Q4 2025, Common Equity rose 10.4% year-over-year to $272.2 million; the TTM value through Dec 2025 reached $272.2 million, up 10.4%, while the annual FY2025 figure was $272.2 million, 10.4% up from the prior year.
  • Common Equity reached $272.2 million in Q4 2025 per CLB's latest filing, down from $277.4 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $277.4 million in Q3 2025 to a low of $173.8 million in Q2 2022.
  • Average Common Equity over 4 years is $231.8 million, with a median of $237.4 million recorded in 2024.
  • Peak YoY movement for Common Equity: increased 26.38% in 2023, then increased 8.18% in 2025.
  • A 4-year view of Common Equity shows it stood at $183.5 million in 2022, then grew by 22.26% to $224.4 million in 2023, then rose by 9.89% to $246.6 million in 2024, then increased by 10.4% to $272.2 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Common Equity are $272.2 million (Q4 2025), $277.4 million (Q3 2025), and $267.3 million (Q2 2025).